Home United States USA — Political Iran Begins Importing Cuban Coronavirus Vaccine Candidates

Iran Begins Importing Cuban Coronavirus Vaccine Candidates

270
0
SHARE

The Islamic dictatorship of Iran celebrated the arrival Thursday of 100,000 doses of coronavirus vaccine candidates made in Cuba, which claims to have four …
The Islamic dictatorship of Iran celebrated the arrival Thursday of 100,000 doses of coronavirus vaccine candidates made in Cuba, which claims to have four such products in development. Iran and Cuba are close diplomatic partners and both claim to be developing vaccines against the Chinese coronavirus. Cuba has registered four experimental coronavirus vaccine products with the World Health Organization (W.H.O.)’s tracking database of products. The most advanced of the four, “Soberana 02,” reportedly began Phase III clinical trials this month. Tehran has divulged little about its alleged coronavirus vaccine candidate, other than the fact Cuba will host human trials. The Iranian regime has also made several other dubious scientific claims, like alleging the Islamic Revolutionary Guard Corps (IRGC), a U.S.-designated terrorist organization, was working on its own vaccine product and had developed a “ magnetic ” device that detects coronavirus in patients. Iran’s Tasnim news agency did not specify which of Cuba’s vaccine candidates had arrived in the country this week. “The aircraft carrying the first shipment, including 100,000 doses of the vaccine, landed at Tehran’s Imam Khomeini International Airport this afternoon,” Tasnim reported. “Earlier, Iran had taken delivery of four consignments of the Russian-made Sputnik-V and one shipment of the Chinese-made Sinopharm COVID-19 [Chinese coronavirus] vaccines.” The outlet did not provide any information on when those vaccine doses would be available to Iranian patients or if doctors would administer them to the general public or select groups. It did note the Cuban products would join increasingly large numbers of doses of “Sputnik V,” the vaccine candidate developed in Russia, after Tehran and Moscow agreed on a deal allowing domestic production of the vaccine in Iran.

Continue reading...